Cenra Inc. (3716) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 中化控股

Cenra Inc. (3716) reported revenue of NT$746.3 million for Oct 2026, +5.3% year on year and +10.6% from the previous month. Revenue for Jan–Oct 2026 was NT$6.95 billion (-2.4% year on year).

In Oct 2026, it ranked No. 10 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$741.2 million24/10Nov 2024 NT$725.9 millionDec 2024 NT$800.3 millionJan 2025 NT$856.6 millionFeb 2025 NT$669.5 million25/02Mar 2025 NT$726.9 millionApr 2025 NT$720.6 millionMay 2025 NT$689.8 millionJun 2025 NT$701.6 million25/06Jul 2025 NT$647 millionAug 2025 NT$639.4 millionSep 2025 NT$758.7 millionOct 2025 NT$709.1 million25/10Nov 2025 NT$678.8 millionDec 2025 NT$770.3 millionJan 2026 NT$880.2 millionFeb 2026 NT$621.6 million26/02Mar 2026 NT$727.7 millionApr 2026 NT$675.7 millionMay 2026 NT$659.3 millionJun 2026 NT$663.8 million26/06Jul 2026 NT$669.8 millionAug 2026 NT$631.8 millionSep 2026 NT$674.9 millionOct 2026 NT$746.3 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$746.3 million+5.3%+10.6%
Sep 2026NT$674.9 million-11.0%+6.8%
Aug 2026NT$631.8 million-1.2%-5.7%
Jul 2026NT$669.8 million+3.5%+0.9%
Jun 2026NT$663.8 million-5.4%+0.7%
May 2026NT$659.3 million-4.4%-2.4%
Apr 2026NT$675.7 million-6.2%-7.2%
Mar 2026NT$727.7 million+0.1%+17.1%
Feb 2026NT$621.6 million-7.2%-29.4%
Jan 2026NT$880.2 million+2.8%+14.3%
Dec 2025NT$770.3 million-3.7%+13.5%
Nov 2025NT$678.8 million-6.5%-4.3%
Oct 2025NT$709.1 million-4.3%-6.5%
Sep 2025NT$758.7 million+1.3%+18.7%
Aug 2025NT$639.4 million—-1.2%
Jul 2025NT$647 million—-7.8%
Jun 2025NT$701.6 million—+1.7%
May 2025NT$689.8 million—-4.3%
Apr 2025NT$720.6 million—-0.9%
Mar 2025NT$726.9 million—+8.6%
Feb 2025NT$669.5 million—-21.8%
Jan 2025NT$856.6 million—+7.0%
Dec 2024NT$800.3 million—+10.2%
Nov 2024NT$725.9 million—-2.1%
Oct 2024NT$741.2 million—-1.0%

Jan–Oct 2026 cumulative: NT$6.95 billion (-2.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Cenra Inc. vs PEC / Cenra Inc. vs Lotus Pharm / Cenra Inc. vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16